Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MDBH
MDBH logo

MDBH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.980
Open
2.980
VWAP
2.98
Vol
589.00
Mkt Cap
30.21M
Low
2.980
Amount
1.75K
EV/EBITDA(TTM)
--
Total Shares
10.14M
EV
12.55M
EV/OCF(TTM)
--
P/S(TTM)
19.14
MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, MDB Minnesota One, Inc. Its segments include broker dealer & intellectual property service, and technology development. The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence. The technology development segment includes MDB Minnesota One, Inc., a research and development stage company that is developing a small molecule senescence platform. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations.
Show More

Events Timeline

(ET)
2025-06-02
17:54:11
MDB Capital announces board transitions
select
2025-05-27 (ET)
2025-05-27
16:12:20
ClearSign Board to expand in size to seven directors
select
2025-05-21 (ET)
2025-05-21
09:04:20
MDB Capital provides Q1 update, continued to work on new opportunities
select
2025-02-21 (ET)
2025-02-21
16:07:58
eXoZymes president, chairman Hayat transitions out of roles
select

News

seekingalpha
9.5
03-31seekingalpha
PinnedMDB Capital Holdings FY 2025 Operating Expense Overview
  • Annual Operating Expenses: MDB Capital Holdings reported fixed operating expenses of approximately $10 million for FY 2025, which includes a $4 million investment in the MDB Direct/Public Ventures clearing platform, indicating a commitment to enhancing its technological infrastructure.
  • Cash Position: At year-end, the company held approximately $22.3 million in cash, current assets, and marketable securities after liabilities, reflecting strong financial health and effective liquidity management.
  • Investment Expenditure: The cash used for PatentVest.Net in FY 2025 was approximately $5.7 million, showcasing the company's strategic focus on intellectual property management and related technologies to bolster its competitive edge in the market.
  • Financial Health: MDB Capital Holdings' financial data indicates that despite fixed operating expenses and investment outlays, the company maintains a solid cash reserve, positioning itself well for future business growth and investment opportunities.
Newsfilter
7.5
03-31Newsfilter
Amylin Drug Market New Opportunities
  • Surge in Market Investment: Over the past 18 months, more than $19 billion in deal value has been committed in the amylin space, with major pharmaceutical companies like Novo Nordisk, Eli Lilly, Roche, Pfizer, and AbbVie actively positioning themselves, indicating strong confidence in the obesity drug market.
  • Rich R&D Pipeline: Nearly 40 amylin receptor agonist programs are currently in development worldwide, with the first GLP-1/amylin combination therapy approaching FDA decision, signaling significant market potential.
  • Significant Efficacy: Clinical data demonstrates that amylin-based therapies can achieve over 20% weight loss, further enhancing their competitiveness in obesity treatment and attracting increased investor interest.
  • Importance of Patent Strategy: Patent strategy plays a critical role in determining long-term competitive advantage, as noted by PatentVest's Chief IP Officer Will Rosellini, who emphasizes that future winners will be those with sophisticated intellectual property architecture, not just the best molecules.
Newsfilter
2.0
03-30Newsfilter
PatentVest Launches IP Legal Insights Platform for Innovators
  • IP Legal Insights Platform: PatentVest has launched a new IP Legal Insights section aimed at providing founders, executives, and investors with expert analysis on how intellectual property decisions impact innovation and competitive positioning, thereby enhancing long-term business value.
  • AI Patent Application Guidance: The latest article explores the patent application process for AI-assisted inventions, emphasizing key considerations such as patent eligibility, inventorship challenges, and effective prosecution strategies to help companies navigate the complex legal landscape.
  • Technological Improvements and Applications: The article highlights that patentability often depends on claiming strategies, including demonstrating technological improvements and practical applications, while emphasizing the human contribution to the inventive process to ensure legal protection for AI-driven innovations.
  • Industry Trend Analysis: PatentVest's legal and technical experts provide analysis on key patent law developments and emerging trends in industries such as biotechnology, healthcare, and artificial intelligence, assisting companies in maintaining a competitive edge in rapidly changing markets.
Newsfilter
6.5
02-26Newsfilter
Analysis of Oral Small-Molecule GLP-1 Drug Competition
  • Significant Market Potential: The injectable GLP-1 drug market has reached $71 billion but covers less than 5% of eligible patients, indicating a vast 95% market potential for oral small-molecule drugs, presenting substantial future growth opportunities.
  • Patent Portfolio Disparities: An analysis of over 1,200 patent documents reveals dramatic disparities in patent depth among programs at similar development stages, which will significantly impact their market competitiveness and long-term viability.
  • Scarcity of Partnership Opportunities: Since 2023, over $47 billion in GLP-1-related deal value has been committed, yet most oral programs remain unpartnered, highlighting potential opportunities and risks in market consolidation.
  • Importance of Patent Protection: With the patent cliffs for semaglutide and tirzepatide approaching, possessing broad patent protection will determine which assets can dominate the market and which may face early generic competition.
Newsfilter
5.0
02-03Newsfilter
MDB Capital Appoints New Board Member
  • Board Changes: MDB Capital Holdings announced the appointment of Jeb Terry to its Board of Directors while expressing gratitude to Susanne Meline for her contributions, effective February 1, 2026, reflecting the company's ongoing commitment to leadership optimization.
  • New Board Member Background: Jeb Terry brings over 20 years of investment experience in microcap medical and biotechnology sectors, having founded Aberdeen Investment Management with a focus on undervalued opportunities in life sciences, which is expected to provide MDB with valuable industry insights.
  • Strategic Implications: The addition of the new board member is seen as a crucial step for MDB in expanding its founder and investor community, with CEO Christopher Marlett emphasizing that Terry's expertise will aid the company's further development in public venture capital.
  • Future Outlook: MDB Capital remains committed to driving the growth of innovative companies through its unique public venture capital platform, focusing on early public offerings and follow-on financings to support promising enterprises.
Globenewswire
1.0
2025-12-11Globenewswire
Keiretsu Forum Hosts Successful Investor Conferences, Attracting Over 150 Investors
  • Investor Gathering: The Southeast Investor Conference and Mid-Atlantic Investor Summit attracted over 150 accredited investors and family offices, fostering in-depth discussions on early-stage capital and developing pathways for higher-quality deal flow.
  • Significant Outcomes: The Atlanta conference featured 75 investors and over 20 presentations, showcasing 10 actively funding companies, which significantly boosted investor confidence and engagement in the market.
  • Exit Strategy Optimization: The Philadelphia summit emphasized disciplined portfolio strategies and time-to-exit, proposing structured financing and 'restart' strategies to shorten exit timelines, thereby enhancing investor return expectations.
  • Future Outlook: Keiretsu Forum plans to continue its Investor Summit series in 2026, expecting to attract more local innovation-stage startups and further drive the development of the regional investment ecosystem.

Valuation Metrics

The current forward P/E ratio for MDB Capital Holdings LLC (MDBH.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess MDB Capital Holdings LLC's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

con rentabilidad alta a corto plazo
Intellectia · 61 candidates
Price: <= $20.00Quarter Revenue Yoy Growth: >= 20.0%Quarter Eps Yoy Growth: >= 15.0%Relative Vol: >= 1.50
Ticker
Name
Market Cap$
top bottom
RBKB logo
RBKB
Rhinebeck Bancorp Inc
134.53M
BZAI logo
BZAI
Blaize Holdings Inc
255.60M
XLO logo
XLO
Xilio Therapeutics Inc
40.33M
LXRX logo
LXRX
Lexicon Pharmaceuticals Inc
566.90M
IBRX logo
IBRX
Immunitybio Inc
6.82B
MDBH logo
MDBH
MDB Capital Holdings LLC
33.86M

Whales Holding MDBH

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is MDB Capital Holdings LLC (MDBH) stock price today?

The current price of MDBH is 2.98 USD — it has increased 0

What is MDB Capital Holdings LLC (MDBH)'s business?

MDB Capital Holdings, LLC is a holding company that has three subsidiaries: MDB CG Management Company (MDB Management), Public Ventures, LLC (Public Ventures), and PatentVest, Inc. (PatentVest), and has a partner company, MDB Minnesota One, Inc. Its segments include broker dealer & intellectual property service, and technology development. The broker dealer & intellectual property service segment has two subsidiaries, Public Ventures and PatentVest. Public Ventures is a full-service broker dealer firm focusing on conducting private and public securities offerings. PatentVest offers in-depth patent research used for investment banking due diligence. The technology development segment includes MDB Minnesota One, Inc., a research and development stage company that is developing a small molecule senescence platform. MDB Management is an administrative entity whose purpose is to conduct, and wherever possible, to consolidate shared services/resources, for its United States-based operations.

What is the price predicton of MDBH Stock?

Wall Street analysts forecast MDBH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MDBH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is MDB Capital Holdings LLC (MDBH)'s revenue for the last quarter?

MDB Capital Holdings LLC revenue for the last quarter amounts to 2.53M USD, increased 88.61

What is MDB Capital Holdings LLC (MDBH)'s earnings per share (EPS) for the last quarter?

MDB Capital Holdings LLC. EPS for the last quarter amounts to USD, decreased -100.00

How many employees does MDB Capital Holdings LLC (MDBH). have?

MDB Capital Holdings LLC (MDBH) has 16 emplpoyees as of April 01 2026.

What is MDB Capital Holdings LLC (MDBH) market cap?

Today MDBH has the market capitalization of 30.21M USD.